Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
315.40    0.40 (0.13%)
Bid:
315.20
Ask:
315.80
Spread: 0.60 (0.19%)
Market Cap: £690.94m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Burford Capital Completes $175 Million Placing

9 Dec 2010 11:00

RNS Number : 6606X
Burford Capital
09 December 2010
 



9 December 2010

 

 

 

Burford Capital Completes $175 Million Placing1

Capital now exceeds $300 million for litigation and dispute investing

 

Burford Capital Limited ("Burford" or the "Company") is pleased to announce the completion of its placing of approximately $175 million (£110 million) following approval of all proposed resolutions at the Company's extraordinary general meeting held today. Application has been made to the London Stock Exchange for the Placing Shares, consisting of 100,000,000 ordinary shares, to be admitted to trading on AIM, which is expected to occur on Friday 10 December 2010.

 

Sir Peter Middleton, Hugh Steven Wilson and David Lowe, directors of the Company ("Directors"), all participated in the Placing, doubling their existing shareholdings, and the shareholders of Burford's investment adviser (the "Principals"), took direct ownership of the shares previously held by Burford Group and have agreed to an extension of the lock-up period to 23 August 2013. Following the Placing and the transfer of shares referred to above, the resulting shareholdings in the Company of the Directors and the Principals will be as follows:

 

Directors

Shares

% of issued share capital

Sir Peter Middleton

60,000

0.03

Hugh Steven Wilson

100,000

0.06

David Lowe

100,000

0.06

Principals

Shares

% of issued share capital

Glenavy Capital LLC (Christopher Bogart)

888,563

0.49

Litigation Risk Solutions LLC (Jonathan Molot)

541,667

0.30

Burford Advisors LLC (Selvyn Seidel)

194,770

0.11

 

Terms defined in the circular posted to Burford Shareholders on 24 November 2010 have the same meaning in this announcement, unless the context requires otherwise.

 

 

1 Subject to admission of the Placing Shares to trading on AIM.

 

 

For further information, please contact:

 

Macquarie Capital (Europe) Limited

Joint Bookrunner, Broker and Nomad

Jonny Franklin-Adams

+44 (0) 20 3037 5231

Steve Baldwin

+44 (0) 20 3037 2362

Execution Noble Limited

Joint Bookrunner and Broker

Richard Crawley

+44 (0) 20 7456 9191

Nigel Morris-Jones

Financial Dynamics

Nick Henderson

+44 (0) 20 7269 7114

Laura Pope

+44 (0) 20 7269 7243

 

 

www.burfordcapital.com

 

About Burford Capital

 

Burford Capital's strategy is to create and manage a portfolio of commercial dispute financing investments diversified by duration, claim type, geography and a number of other variables, with the aim of providing shareholders with attractive levels of dividends and capital growth. The Company expects returns to be uncorrelated to general equity market performance.

 

In the short term, the Company's focus is on commercial disputes in the United States and on international arbitration matters; in the medium term, the Company may expand its focus to other attractive and suitable jurisdictions.

 

Burford Group Limited acts as Investment Adviser to the Company -www.burfordgroupltd.com.

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUKORRRVAURAA
Date   Source Headline
2nd Jul 202611:00 amRNSIssue of Equity in Connection with LTIP
25th Jun 202611:00 amRNSIssue of Equity in Connection with NED Plan Grants
17th Jun 202612:00 pmRNSDirector/PDMR Shareholding & Equity Issue re DCP
29th May 20262:00 pmRNSSterling FX Rate for 2025 Final Dividend
21st May 202612:00 pmRNSNotice of Retail Shareholder Audio Webcast
14th May 202612:00 pmRNSResult of AGM
8th May 202612:00 pmRNS1Q26 Financial Results
5th May 202612:00 pmRNSNotice of 1Q26 Results & Results Call Details
7th Apr 20267:00 amRNSHolding(s) in Company
31st Mar 20267:00 amRNSDirector/PDMR Shareholding & Issue of Equity
30th Mar 20267:00 amRNSBurford Capital Further Statement on YPF
30th Mar 20267:00 amRNSBurford Capital Statement Re YPF Appeal Decision
27th Mar 20263:32 pmRNSBurford Capital Statement re YPF Matter
17th Mar 202612:00 pmRNSCompletion of Share Repurchase Program
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
26th Feb 20261:00 pmRNSAnnual Results for Year Ended December 31, 2025
10th Feb 20261:00 pmRNSNotice of 2025 Results & Results Call Details
27th Jan 20261:30 pmRNSPricing of Early Redemption of Bonds Due 2026
15th Jan 20263:41 pmRNSNotice of Early Redemption of Bonds Due 2026
15th Jan 20267:00 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSPricing and Upsizing of Senior Notes Offering
12th Jan 20262:01 pmRNSPrivate Offering of Senior Notes
5th Jan 20261:00 pmRNSIssue of New Shares in Connection with LTIP
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:00 amRNSDirector/PDMR Shareholding
4th Dec 20251:00 pmRNSDirector/PDMR Shareholding
7th Nov 20251:00 pmRNSSterling Conversion Rate for 2025 Interim Dividend
6th Nov 20257:00 amRNSHolding(s) in Company
5th Nov 20251:00 pmRNSAppointment of Joint Corporate Broker
5th Nov 20251:00 pmRNS3Q25 and YTD25 Financial Results
29th Oct 20257:00 amRNSHolding(s) in Company
24th Oct 20257:00 amRNSHolding(s) in Company
23rd Oct 20251:00 pmRNSNotice of 3Q25 Results & Results Call Details
22nd Oct 20251:00 pmRNSYPF Matter Update
10th Oct 20257:00 amRNSHolding(s) in Company
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding & New Share Issuance
1st Oct 20252:00 pmRNSHolding(s) in Company
29th Sep 20251:00 pmRNSInterim Dividend Declaration
29th Sep 20257:00 amRNSHolding(s) in Company
23rd Sep 20259:00 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSDirector/PDMR Shareholding
7th Aug 20251:00 pmRNS2Q25 and YTD25 Financial Results
24th Jul 202512:00 pmRNSNotice of 2Q25 Results & Results Call Details
14th Jul 202512:00 pmRNSClosing of Private Offering of Senior Notes
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
8th Jul 20255:21 pmRNSPricing and Upsizing of Senior Notes Offering

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.